Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
42 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07809841 | Real-Time AI During Pancreatoscopy for Detection of Pancreatic Neoplasia | not yet recruiting | — | 60 | Instituto Ecuatoriano de Enfermedades DigestivasOTHER | 1 | Sep 9, 2026 | clinicaltrials |
| NCT03259763 | EUS-GE vs ES for Palliation of Gastric Outlet Obstruction | completed | N/A | 112 | Johns Hopkins UniversityOTHER | 7 | Jul 6, 2026 | clinicaltrials |
| NCT07490548 | Lifestyle Medicine Adherence, Mental Wellbeing, and Quality of Life in Pediatric Oncology in Ecuador | enrolling by invitation | — | 62 | Universidad de Especialidades Espiritu SantoOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT06813950 | Impact of a Physical Activity Program on the Health-Related Quality of Life in Pediatric Cancer Patients | not yet recruiting | N/A | 80 | Sociedad de Lucha Contra el CáncerOTHER | 1 | Feb 11, 2025 | clinicaltrials |
| NCT06304610 | Hospital-based Validation of the New ELEVATE Screening Tool(ELEVATE-Pilot) | not yet recruiting | N/A | 200 | University Hospital, GhentOTHER | 2 | Jan 27, 2025 | clinicaltrials |
| NCT06136702 | ELEVATE Acceptability Study(ELEVATE AS) | unknown | N/A | 1,048 | University GhentOTHER | 4 | Nov 18, 2023 | clinicaltrials |
| NCT05453292 | Endoscopic Ultrasound Radiofrequency Ablation for GISTs | unknown | N/A | 30 | Instituto Ecuatoriano de Enfermedades DigestivasOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT05474794 | Detective Flow Imaging Endoscopic Ultrasonography in Subepithelial Lesions | unknown | N/A | 30 | Instituto Ecuatoriano de Enfermedades DigestivasOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT05542030 | CAD EYE Detection of Remaining Lesions After EMR | unknown | N/A | 60 | Instituto Ecuatoriano de Enfermedades DigestivasOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT05734820 | Computer-aided Detection During Screening Colonoscopy | unknown | N/A | 312 | Instituto Ecuatoriano de Enfermedades DigestivasOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT05834426 | Omic Technologies Applied to the Study of B-cell Lymphoma for the Discovery of Diagnostic and Prognosis Biomarkers | unknown | — | 50 | Sociedad de Lucha Contra el Cáncer del EcuadorOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT05850377 | 5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas | unknown | — | 90 | Sociedad de Lucha Contra el Cáncer del EcuadorOTHER | 1 | May 9, 2023 | clinicaltrials |
| NCT05825326 | Epidemiological and Clinical-pathological Factors of Philadelphia-negative Myeloproliferative Neoplasms in Ecuador | completed | — | 40 | Sociedad de Lucha Contra el Cáncer del EcuadorOTHER | 1 | Apr 27, 2023 | clinicaltrials |
| NCT05374122 | AI Guidance for Biopsy in Suspected Cholangiocarcinoma | unknown | N/A | 48 | Instituto Ecuatoriano de Enfermedades DigestivasOTHER | 1 | Mar 6, 2023 | clinicaltrials |
| NCT05147389 | Artificial Intelligence for Digital Cholangioscopy Neoplasia Diagnosis | completed | — | 170 | Instituto Ecuatoriano de Enfermedades DigestivasOTHER | 4 | Nov 17, 2022 | clinicaltrials |
| NCT02594371 | Ph3 Study To Determine Safety,Tolerability&Tumor Response Of Oraxol Compared To Taxol In Metastatic Breast Cancer | completed | Phase 3 | 402 | Athenex, Inc.INDUSTRY | 10 | Aug 3, 2022 | clinicaltrials |
| NCT01702571 | A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment | completed | Phase 3 | 2,185 | Hoffmann-La RocheINDUSTRY | 43 | Apr 4, 2022 | clinicaltrials |
| NCT04915833 | Computer-aided Detection During Screening Colonoscopy (Experts) | unknown | N/A | 209 | Instituto Ecuatoriano de Enfermedades DigestivasOTHER | 1 | Mar 31, 2022 | clinicaltrials |
| NCT05095831 | EUS Shear Wave for Solid Pancreatic Lesions. | unknown | — | 25 | Instituto Ecuatoriano de Enfermedades DigestivasOTHER | 1 | Jan 4, 2022 | clinicaltrials |
| NCT03901651 | Combined Forward and Retroflexion Withdrawal in the Detection of Polyps and Adenoma During Colonoscopy | completed | N/A | 203 | Instituto Ecuatoriano de Enfermedades DigestivasOTHER | 1 | Jun 2, 2021 | clinicaltrials |
| NCT01566721 | A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer(SafeHER) | completed | Phase 3 | 2,577 | Hoffmann-La RocheINDUSTRY | 59 | Apr 27, 2021 | clinicaltrials |
| NCT01572038 | A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer(PERUSE) | completed | Phase 3 | 1,436 | Hoffmann-La RocheINDUSTRY | 39 | Sep 25, 2020 | clinicaltrials |
| NCT03729882 | Primary EUS-GBD in Patients With Unresectable Malignant Biliary Obstruction and Cystic Duct Orifice Involvement. | completed | N/A | 22 | Instituto Ecuatoriano de Enfermedades DigestivasOTHER | 1 | Jul 28, 2020 | clinicaltrials |
| NCT00088530 | BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL) | completed | Phase 3 | 140 | CTI BioPharmaINDUSTRY | 20 | Feb 5, 2020 | clinicaltrials |
| NCT00567190 | A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer(CLEOPATRA) | completed | Phase 3 | 808 | Genentech, Inc.INDUSTRY | 26 | Dec 13, 2019 | clinicaltrials |
| NCT04137666 | NRS 2002: Nutritional Screen in Cancer Patients | completed | — | 68 | Sociedad de Lucha Contra el Cáncer del EcuadorOTHER | 1 | Oct 24, 2019 | clinicaltrials |
| NCT03155165 | Retroview™ Colonoscope and Lesion Detection Rate | completed | — | 100 | Instituto Ecuatoriano de Enfermedades DigestivasOTHER | 1 | Feb 27, 2019 | clinicaltrials |
| NCT00338286 | A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy | completed | Phase 3 | 2,098 | Janssen Research & Development, LLCINDUSTRY | 21 | Mar 19, 2018 | clinicaltrials |
| NCT03401411 | ICU Triage Practices in a Cancer Hospital | completed | N/A | 257 | M.D. Anderson Cancer CenterOTHER | 2 | Feb 28, 2018 | clinicaltrials |
| NCT01307397 | A Study of Vemurafenib in Participants With Metastatic Melanoma | completed | Phase 3 | 3,219 | Hoffmann-La RocheINDUSTRY | 44 | Dec 18, 2017 | clinicaltrials |
| NCT00430352 | MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma. | completed | Phase 4 | 545 | Hoffmann-La RocheINDUSTRY | 24 | Aug 14, 2017 | clinicaltrials |
| NCT00806819 | Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC | completed | Phase 3 | 718 | Boehringer IngelheimINDUSTRY | 32 | Feb 2, 2017 | clinicaltrials |
| NCT00930514 | A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular Lymphoma | completed | Phase 1 | 281 | Hoffmann-La RocheINDUSTRY | 22 | Nov 2, 2016 | clinicaltrials |
| NCT00949910 | An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 4 | 6,586 | Hoffmann-La RocheINDUSTRY | 51 | Oct 5, 2016 | clinicaltrials |
| NCT00451906 | A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer. | completed | Phase 4 | 2,252 | Hoffmann-La RocheINDUSTRY | 40 | May 24, 2016 | clinicaltrials |
| NCT00448591 | A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer. | completed | Phase 3 | 2,296 | Hoffmann-La RocheINDUSTRY | 36 | May 25, 2015 | clinicaltrials |
| NCT00130897 | Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma | approved for marketing | — | — | PfizerINDUSTRY | 50 | Mar 9, 2012 | clinicaltrials |
| NCT00715637 | Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study | unknown | Phase 3 | 420 | Antisoma ResearchINDUSTRY | 23 | Oct 13, 2010 | clinicaltrials |
Data updated 20 days agoSource updated unknownsource: clinicaltrials